⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12328032 | 0.55 | — | — | |
| SCHEMBL18300214 | 0.50 | — | — | |
| SCHEMBL13937854 | 0.46 | — | — | |
| SCHEMBL11977614 | 0.46 | — | — | |
| SCHEMBL10072613 | 0.46 | — | — | |
| SCHEMBL14401563 | 0.45 | — | — | |
| SCHEMBL19594928 | 0.41 | — | — | |
| SCHEMBL6014437 | 0.40 | — | — | |
| SCHEMBL8004943 | 0.40 | — | — | |
| SCHEMBL12432547 | 0.39 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008115990-A1 | METHODS OF PREPARATION AND RESOLUTION OF E/Z ISOMERS OF VINYLFURO[2,3-D] PYRIMIDINE AND THEIR BIOLOGICAL ACTIVITIES AND RELATED COMPOSITIONS AND METHODS OF TREATMENT | DUQUESNE UNIVERSITY OF THE HOLY GHOST (US) | 2008-09-25 | — | — | WO | disclosed |
| US-20070238742-A1 | METHODS OF PREPARATION AND RESOLUTION OF E/Z ISOMERS OF VINYLFURO[2,3-D]PYRIMIDINE AND THEIR BIOLOGICAL ACTIVITIES AND RELATED COMPOSITIONS AND METHODS OF TREATMENT | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2007-10-11 | — | — | US | disclosed |
| US-6962920-B2 | Pyrimidine derivatives and methods of making and using these derivatives | DUQUESNE UNIVERSITY OF THE HOLY GHOST (US) | 2005-11-08 | — | — | US | disclosed |
| US-20040039000-A1 | Novel pyrimidine derivatives and methods of making and using these derivatives | GANGJEE ALEEM (US) | 2004-02-26 | — | — | US | disclosed |
| US-6696455-B1 | NITROGEN COMPOUNDS SUCH AS 6-CHLORO-2-METHYL-4-OXO-PYRIDO (3,2-D)PYRIMIDINE USED AS ANTICARCINOGENIC AGENTS AND/OR FOR PROPHYLAXIS OF INFECTIONS CAUSED BY PNEUMOCYSTIS OR TOXOPLASMA | DUQUESNE UNIVERSITY OF THE HOLY GHOST | 2004-02-24 | — | — | US | disclosed |
| US-20030144509-A1 | Pyrimidine derivatives and methods of making and using these derivatives | GANGJEE ALEEM (US) | 2003-07-31 | — | — | US | disclosed |
| US-6537999-B2 | Furopyrimidines and pyrrolopyrimidines; treating cancer, and secondary infections caused by Pneumocystis carinii and Toxoplasmosis gondii in immunocompromised patients. | DUQUESNE UNIVERSITY OF THE HOLY GHOST | 2003-03-25 | — | — | US | disclosed |
| US-6518426-B1 | Novel pyrrolo(3,2-d)pyrimidine derivatives of the following general formula compounds are useful in the treatment of bacterial infections such as Toxoplasmosis gondii and Pneumocystis carinii, and various types of cancer, | DUQUESNE UNIVERSITY OF THE HOLY GHOST | 2003-02-11 | — | — | US | disclosed |
| US-6420370-B1 | ANTITUMOR, ANTIBIOTIC, ANTIMALARIAL, ANTIFUNGAL OR ANTIPROTOZOAL AGENTS, OR AS SYNERGISTIC AGENTS ENZYME INHIBITORS | DUQUESNE UNIVERSITY OF THE HOLY GHOST | 2002-07-16 | — | — | US | disclosed |
| US-20020052384-A1 | Novel pyrimidine derivatives and methods of making and using these derivatives | GANGJEE ALEEM (US) | 2002-05-02 | — | — | US | disclosed |
| US-6096750-A | Furopyrimidines and methods of making and using the same derivatives | DUQUESNE UNIVERSITY OF THE HOLY GHOST (US) | 2000-08-01 | — | — | US | disclosed |
| US-6077844-A | FOR TREATING ILLNESSES SUCH AS CANCER, AND SECONDARY INFECTIONS CAUSED BY PNEUMOCYSTIS CARINII AND TOXOPLASMOSIS GONDII IN IMMUNOCOMPROMISED PATIENTS | DUQUESNE UNIVERSITY OF THE HOLY GHOST (US) | 2000-06-20 | — | — | US | disclosed |
| US-5958930-A | TREATING CANCER, AND SECONDARY INFECTIONS CAUSED BY PNEUMOCYSTIS CARINII AND TOXOPLASMOSIS GONDII IN IMMUNOCOMPROMISED PATIENTS. | DUQUESNE UNIVERSITY OF THE HOLY GHOST (US) | 1999-09-28 | — | — | US | disclosed |
| US-5939420-A | BACTERICIDES CAUSED BY PNEUMOCYSTIS AND TOXOPLASMOSIS, ANTITUMOR AGENTS AND ANTICARCINOGENIC AGENTS | DUQUESNE UNIVERSITY OF THE HOLY GHOST (US) | 1999-08-17 | — | — | US | disclosed |
| US-5877178-A | AIDS THERAPY | DUQUESNE UNIVERSITY OF THE HOLY GHOST (US) | 1999-03-02 | — | — | US | disclosed |
| US-5866580-A | TREATING AN ILLNESS CAUSED BY P. CARINII AND T. GONDII | DUGUESNE UNIVERSITY OF THE HOLY GHOST (US) | 1999-02-02 | — | — | US | disclosed |
| US-5863920-A | ANTICARCINOGENIC AGENTS AND BACTERICIDES | DUQUESNE UNIVERSITY OF THE HOLY GHOST (US) | 1999-01-26 | — | — | US | disclosed |
| US-5508281-A | TREATING ILLNESS CAUSED BY PNEUMOCYSTIS CARINII OR TOXOPLASMOSIS GONDII | DUQUESNE UNIVERSITY OF THE HOLY GHOST (US) | 1996-04-16 | — | — | US | disclosed |
| US-5346900-A | Reductase inhibitors active against Pneumocystis and Toxoplasmosis | DUQUESNE UNIVERSITY OF THE HOLY GHOST (US) | 1994-09-13 | — | — | US | disclosed |
| WO-1992017478-A1 | 5-ALKYL-6-[[AMINO]METHYL]PYRIDO[2,3-d]PYRIMIDINE DERIVATIVES AND METHODS OF PREPARING AND USING THESE DERIVATIVES | DUQUESNE UNIVERSITY OF THE HOLY GHOST (US) | 1992-10-15 | — | — | WO | disclosed |